PPARGC1A and metabolic dysfunction-associated steatotic liver disease: Activation of elements within the FGF21/AMPK/PGC-1α cascade is crucial in regulating mitochondrial energy metabolism and has attracted considerable attention as a potential therapeutic target for addressing metabolic disorders like NAFLD.